Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
132.00    -3.50 (-2.58%)
Bid:
133.00
Ask:
139.50
Spread: 6.50 (4.887%)
Market Cap: £103.58m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Board Change

23 Feb 2024 10:30

RNS Number : 1814E
Xaar PLC
23 February 2024
 

23 February 2024

Xaar plc

Board Change

Xaar plc, ("the Company" or "Xaar"), a leading inkjet printing technology group, announces today the appointment of Stuart Widdowson to the Board as a Non-Executive Director effective from 27 February 2024.

Mr Widdowson is appointed as a representative of Odyssean Capital LLP ("Odyssean"), pursuant to a relationship agreement between the Company and Odyssean. The key terms are summarised in the notes below.

Mr Widdowson is the Managing Partner of Odyssean Capital, which he founded in 2017. From 2009 until 2017, he was lead fund manager of Strategic Equity Capital plc, which experienced a turnaround in its performance and rating during his tenure. He began his career as a strategy consultant undertaking commercial due diligence and strategy projects for private equity and corporate clients, before working for HgCapital, a leading private equity investor.

As at the last practicable date the total shareholding of funds managed by Odyssean Capital was 13,175,000 ordinary shares in the Company ("Ordinary Shares") representing approximately 16.6 per cent. of the Company's share capital. Additionally, Mr Widdowson beneficially owns 25,000 Ordinary Shares and the joint venture partner of Odyssean Capital, Harwood Capital, owns 1,050,000 Ordinary Shares.

Notes:

A summary of the key terms of the Relationship Agreement is as follows:

· Xaar has granted Odyssean the right to appoint Mr Widdowson to be a Director of the Company for appointment to the Board (the "Nominated Director") for so long as Odyssean has the right to exercise at least 10% or more of the Company's ordinary shares or voting rights attaching to the ordinary shares;

· Odyssean undertakes to, inter alia: (1) conduct all transactions and relationships with any member of Xaar's group on an arm's length basis; (2) not take any action which would have the effect of preventing Xaar or any member of Xaar's group from carrying on business independently of Odyssean or its associates; (3) not influence the day-to-day running of the Company (save through Mr Widdowson's role as the Nominated Director) and (4) not vote to prevent Xaar being managed in accordance with the principles of good governance set out in the UK Corporate Governance Code; and

· the Relationship Agreement will terminate (1) on the date upon which Odyssean ceases to hold at least 10% of the ordinary shares of the Company or the voting rights attaching to the ordinary shares of the Company; (2) on six months' notice written notice by either party at any time or immediately upon written notice in the event of a material breach of the Relationship Agreement; or (3) in the event that the Company's ordinary shares cease to be listed on the Official List or another recognised UK stock exchange.

Pursuant to Listing Rule 9.6.13, it is confirmed that Mr Widdowson was a director and shareholder of Durendal Limited, a fund management business, which was wound up in 2015. His shareholding was acquired by the majority shareholder and the cash was distributed to all shareholders before the company was voluntarily liquidated.

There is no additional information required to be disclosed pursuant to Listing Rule 9.6.13 in relation to the appointment of Stuart Widdowson to the Board.

Enquiries:

Xaar plc

+44 (0) 1223 423 663 

Ian Tichias, Chief Financial Officer

John Mills, Chief Executive Officer

 

Teneo Communications

Giles Kernick

Olivia Lucas

+44 (0) 207 353 4200

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOATTMPTMTTTBFI
Date   Source Headline
4th Jul 20143:06 pmRNSHolding(s) in Company
4th Jul 20143:01 pmRNSHolding(s) in Company
3rd Jul 20149:41 amRNSHolding(s) in Company
1st Jul 201410:38 amRNSTotal Voting Rights
1st Jul 201410:38 amRNSBlocklisting Interim Review
27th Jun 201411:31 amRNSHolding(s) in Company
25th Jun 20145:53 pmRNSHolding(s) in Company
25th Jun 20147:00 amRNSDirector/PDMR Shareholding
24th Jun 20145:05 pmRNSDirector/PDMR Shareholding
20th Jun 20144:13 pmRNSHolding(s) in Company
20th Jun 201410:36 amRNSHolding(s) in Company
20th Jun 201410:19 amRNSHolding(s) in Company
17th Jun 20147:00 amRNSTrading Update
13th Jun 20147:00 amRNSAppointment of Corporate Broker
2nd Jun 20144:00 pmRNSTotal Voting Rights
14th May 20146:10 pmRNSResult of AGM
13th May 20147:00 amRNSGrant of Options
12th May 20145:58 pmRNSDirector/PDMR Shareholding
1st May 201412:10 pmRNSTotal Voting Rights
30th Apr 201411:35 amRNSDirector/PDMR Shareholding
24th Apr 20147:00 amRNSDirector/PDMR Shareholding
23rd Apr 201410:08 amRNSNotice of 2014 AGM & Annual Financial Report
22nd Apr 20144:31 pmRNSDirector/PDMR Shareholding
17th Apr 201412:39 pmRNSDirector/PDMR Shareholding - Replacement
17th Apr 201412:08 pmRNSDirector/PDMR Shareholding
17th Apr 201411:20 amRNSDirector/PDMR Shareholding
16th Apr 20147:00 amRNSXaar plc - Interim Management Statement
10th Apr 20145:40 pmRNSHolding(s) in Company
4th Apr 201411:31 amRNSDirector/PDMR Shareholding
4th Apr 20149:13 amRNSGrant of Options
1st Apr 20149:25 amRNSTotal Voting Rights
28th Mar 20147:02 amRNSDirector/PDMR Shareholding
19th Mar 20143:58 pmRNSDirector/PDMR Shareholding
18th Mar 20147:00 amRNS2013 Full Year Results
13th Mar 20147:00 amRNSXaar plc - XAAR LAUNCHES THE XAAR 1002
28th Feb 201411:57 amRNSTotal Voting Rights
7th Feb 201410:42 amRNSHolding(s) in Company
16th Jan 20147:00 amRNSTrading Statement
7th Jan 20147:00 amRNSBlocklisting Interim Review
2nd Jan 201411:26 amRNSTotal Voting Rights
23rd Dec 20131:47 pmRNSHolding(s) in Company
16th Dec 20133:48 pmRNSHolding(s) in Company
13th Dec 20134:34 pmRNSHolding(s) in Company
13th Dec 20139:23 amRNSHolding(s) in Company
4th Dec 20133:28 pmRNSHolding(s) in Company
4th Dec 20132:20 pmRNSHolding(s) in Company
2nd Dec 20137:00 amRNSDirector/PDMR Shareholding
31st Oct 20134:37 pmRNSTotal Voting Rights
28th Oct 20134:21 pmRNSHolding(s) in Company
17th Oct 20137:00 amRNSInterim Management Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.